IL-2 production and response in vitro by the leukocytes of patients with acquired immune deficiency syndrome

J. M. Reuben, Evan M Hersh, J. Lee Murray

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In order to investigate the nature of the T cell defect associated with the acquired immune deficiency syndrome (AIDS) we studied the ability of peripheral blood mononuclear cells from 8 patients with Kaposi's sarcoma (KS), 2 with opportunistic infection (OI), 23 with AIDS-related symptoms complex (ARC) without KS or OI (ARC), and 29 heterosexual controls to produce interleukin II (IL-2) on phytohemagglutinin (PHA) stimulation and to respond to exogenously supplied IL-2. Patients with AIDS as well as those with ARC produced adequate levels of Il-2 in response to lectin stimulation when compared to controls (AIDS, 3.07 ± 1.98 units; ARC, 3.03 ± 1.89 units; control, 3.75 ± 1.52 units). However, the ability of these patients' cells to respond in vitro to exogenously supplied IL-2 as measured on short-term PHA-stimulated T cell blasts was found to be severely impaired in patients with AIDS and ARC (AIDS, 22.4 ± 6.0 x 10-3 cpm; ARC, 20.1 ± 4.2 x 10-3 cpm; control, 41.4 ± 4.2 x 10-3 cpm). This impairment was associated with diminished expression of the IL-2 receptor on 7-day-old lectin-stimulated T cells from both patient groups (AIDS, 17.7 ± 5.7; ARC, 36.8 ± 4.4; control, 71.8 ± 1.7). These results should be considered when IL-2 is proposed as potential therapy in the treatment of AIDS. They also suggest that the nature of the AIDS defect is related to impaired hormone receptor expression.

Original languageEnglish (US)
Pages (from-to)359-377
Number of pages19
JournalAIDS Research
Volume1
Issue number5
StatePublished - 1983
Externally publishedYes

Fingerprint

Interleukin-2
AIDS-Related Complex
Acquired Immunodeficiency Syndrome
Leukocytes
Aptitude
Kaposi's Sarcoma
Opportunistic Infections
Phytohemagglutinins
T-Lymphocytes
Lectins
In Vitro Techniques
Interleukin-2 Receptors
Heterosexuality
Blood Cells
Hormones
Therapeutics

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

IL-2 production and response in vitro by the leukocytes of patients with acquired immune deficiency syndrome. / Reuben, J. M.; Hersh, Evan M; Lee Murray, J.

In: AIDS Research, Vol. 1, No. 5, 1983, p. 359-377.

Research output: Contribution to journalArticle

@article{88a9491cbcbc4f1da51a45ab10b3af0c,
title = "IL-2 production and response in vitro by the leukocytes of patients with acquired immune deficiency syndrome",
abstract = "In order to investigate the nature of the T cell defect associated with the acquired immune deficiency syndrome (AIDS) we studied the ability of peripheral blood mononuclear cells from 8 patients with Kaposi's sarcoma (KS), 2 with opportunistic infection (OI), 23 with AIDS-related symptoms complex (ARC) without KS or OI (ARC), and 29 heterosexual controls to produce interleukin II (IL-2) on phytohemagglutinin (PHA) stimulation and to respond to exogenously supplied IL-2. Patients with AIDS as well as those with ARC produced adequate levels of Il-2 in response to lectin stimulation when compared to controls (AIDS, 3.07 ± 1.98 units; ARC, 3.03 ± 1.89 units; control, 3.75 ± 1.52 units). However, the ability of these patients' cells to respond in vitro to exogenously supplied IL-2 as measured on short-term PHA-stimulated T cell blasts was found to be severely impaired in patients with AIDS and ARC (AIDS, 22.4 ± 6.0 x 10-3 cpm; ARC, 20.1 ± 4.2 x 10-3 cpm; control, 41.4 ± 4.2 x 10-3 cpm). This impairment was associated with diminished expression of the IL-2 receptor on 7-day-old lectin-stimulated T cells from both patient groups (AIDS, 17.7 ± 5.7; ARC, 36.8 ± 4.4; control, 71.8 ± 1.7). These results should be considered when IL-2 is proposed as potential therapy in the treatment of AIDS. They also suggest that the nature of the AIDS defect is related to impaired hormone receptor expression.",
author = "Reuben, {J. M.} and Hersh, {Evan M} and {Lee Murray}, J.",
year = "1983",
language = "English (US)",
volume = "1",
pages = "359--377",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - IL-2 production and response in vitro by the leukocytes of patients with acquired immune deficiency syndrome

AU - Reuben, J. M.

AU - Hersh, Evan M

AU - Lee Murray, J.

PY - 1983

Y1 - 1983

N2 - In order to investigate the nature of the T cell defect associated with the acquired immune deficiency syndrome (AIDS) we studied the ability of peripheral blood mononuclear cells from 8 patients with Kaposi's sarcoma (KS), 2 with opportunistic infection (OI), 23 with AIDS-related symptoms complex (ARC) without KS or OI (ARC), and 29 heterosexual controls to produce interleukin II (IL-2) on phytohemagglutinin (PHA) stimulation and to respond to exogenously supplied IL-2. Patients with AIDS as well as those with ARC produced adequate levels of Il-2 in response to lectin stimulation when compared to controls (AIDS, 3.07 ± 1.98 units; ARC, 3.03 ± 1.89 units; control, 3.75 ± 1.52 units). However, the ability of these patients' cells to respond in vitro to exogenously supplied IL-2 as measured on short-term PHA-stimulated T cell blasts was found to be severely impaired in patients with AIDS and ARC (AIDS, 22.4 ± 6.0 x 10-3 cpm; ARC, 20.1 ± 4.2 x 10-3 cpm; control, 41.4 ± 4.2 x 10-3 cpm). This impairment was associated with diminished expression of the IL-2 receptor on 7-day-old lectin-stimulated T cells from both patient groups (AIDS, 17.7 ± 5.7; ARC, 36.8 ± 4.4; control, 71.8 ± 1.7). These results should be considered when IL-2 is proposed as potential therapy in the treatment of AIDS. They also suggest that the nature of the AIDS defect is related to impaired hormone receptor expression.

AB - In order to investigate the nature of the T cell defect associated with the acquired immune deficiency syndrome (AIDS) we studied the ability of peripheral blood mononuclear cells from 8 patients with Kaposi's sarcoma (KS), 2 with opportunistic infection (OI), 23 with AIDS-related symptoms complex (ARC) without KS or OI (ARC), and 29 heterosexual controls to produce interleukin II (IL-2) on phytohemagglutinin (PHA) stimulation and to respond to exogenously supplied IL-2. Patients with AIDS as well as those with ARC produced adequate levels of Il-2 in response to lectin stimulation when compared to controls (AIDS, 3.07 ± 1.98 units; ARC, 3.03 ± 1.89 units; control, 3.75 ± 1.52 units). However, the ability of these patients' cells to respond in vitro to exogenously supplied IL-2 as measured on short-term PHA-stimulated T cell blasts was found to be severely impaired in patients with AIDS and ARC (AIDS, 22.4 ± 6.0 x 10-3 cpm; ARC, 20.1 ± 4.2 x 10-3 cpm; control, 41.4 ± 4.2 x 10-3 cpm). This impairment was associated with diminished expression of the IL-2 receptor on 7-day-old lectin-stimulated T cells from both patient groups (AIDS, 17.7 ± 5.7; ARC, 36.8 ± 4.4; control, 71.8 ± 1.7). These results should be considered when IL-2 is proposed as potential therapy in the treatment of AIDS. They also suggest that the nature of the AIDS defect is related to impaired hormone receptor expression.

UR - http://www.scopus.com/inward/record.url?scp=0020979960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020979960&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 359

EP - 377

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 5

ER -